Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stevo Julius

Showing results (61-70 of 118) with videos related to

Pageof 12
Sort By:
Journal of Hypertension|February 7, 2007
Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudyOle Lederballe Pedersen, Giuseppe Mancia, Thomas Pickering, et al.
Annals of Internal Medicine|September 6, 2007
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patientsPeter M Okin, Richard B Devereux, Katherine E Harris, et al.
American Journal of Hypertension|April 10, 2002
A "gender blind" relationship of lean body mass and blood pressure in the Tecumseh studyStevo Julius, Silja Majahalme, Shawna Nesbitt, et al.
American Journal of Hypertension|February 21, 2014
Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapyPeter M Okin, Casper N Bang, Kristian Wachtell, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 19, 2008
The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study designHiroyuki Sasamura, Hideaki Nakaya, Stevo Julius, et al.
Journal of Hypertension|June 15, 2007
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trialLuis M Ruilope, Alberto Zanchetti, Stevo Julius, et al.
Reviews in Cardiovascular Medicine|March 29, 2022
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life StudyAlexander Lilja-Cyron, Casper N Bang, Eva Gerdts, et al.
Journal of Hypertension|March 15, 2006
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus MeetingPaolo Palatini, Athanase Benetos, Guido Grassi, et al.
Hypertension (Dallas, Tex. : 1979)|April 28, 2020
Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel BlockersMaria H Mehlum, Knut Liestøl, Sverre E Kjeldsen, et al.
European Heart Journal|January 25, 2018
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risksMaria H Mehlum, Knut Liestøl, Sverre E Kjeldsen, et al.
Pageof 12

Showing results (61-70 of 118) with videos related to

Sort By:
Pageof 12
Journal of Hypertension|February 7, 2007
Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudyOle Lederballe Pedersen, Giuseppe Mancia, Thomas Pickering, et al.
Annals of Internal Medicine|September 6, 2007
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patientsPeter M Okin, Richard B Devereux, Katherine E Harris, et al.
American Journal of Hypertension|April 10, 2002
A "gender blind" relationship of lean body mass and blood pressure in the Tecumseh studyStevo Julius, Silja Majahalme, Shawna Nesbitt, et al.
American Journal of Hypertension|February 21, 2014
Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapyPeter M Okin, Casper N Bang, Kristian Wachtell, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|November 19, 2008
The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study designHiroyuki Sasamura, Hideaki Nakaya, Stevo Julius, et al.
Journal of Hypertension|June 15, 2007
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trialLuis M Ruilope, Alberto Zanchetti, Stevo Julius, et al.
Reviews in Cardiovascular Medicine|March 29, 2022
Aortic Root Dilatation in Hypertensive Patients with Left Ventricular Hypertrophy-Application of A New Multivariate Predictive Model. The Life StudyAlexander Lilja-Cyron, Casper N Bang, Eva Gerdts, et al.
Journal of Hypertension|March 15, 2006
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus MeetingPaolo Palatini, Athanase Benetos, Guido Grassi, et al.
Hypertension (Dallas, Tex. : 1979)|April 28, 2020
Blood Pressure-Lowering Profiles and Clinical Effects of Angiotensin Receptor Blockers Versus Calcium Channel BlockersMaria H Mehlum, Knut Liestøl, Sverre E Kjeldsen, et al.
European Heart Journal|January 25, 2018
Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risksMaria H Mehlum, Knut Liestøl, Sverre E Kjeldsen, et al.
Pageof 12